These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1963703)

  • 1. The role of TNF in regulation of cell function.
    Espevik T; Shalaby R; Liabakk NB; Waage A; Sundan A
    Scand J Clin Lab Invest Suppl; 1990; 202():160. PubMed ID: 1963703
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiproliferative and antitumor activity of TNF in vitro and in vivo.
    Malik ST; Balkwill FR
    Immunol Ser; 1992; 56():239-68. PubMed ID: 1312874
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tumor necrosis factor].
    Matache C; Neguţ E; Szegli G
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1989; 34(4):289-99. PubMed ID: 2561867
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence for tumor necrosis factor-alpha involvement in the optimal induction of class I allospecific cytotoxic T cells.
    Robinet E; Branellec D; Termijtelen AM; Blay JY; Gay F; Chouaib S
    J Immunol; 1990 Jun; 144(12):4555-61. PubMed ID: 2161875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [TNF and TNF receptors: structure, mechanism of action, role in disease and therapy].
    Morimoto H; Bonavida B
    Nihon Rinsho; 1993 Jul; 51(7):1885-90. PubMed ID: 8396184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural inhibitors of TNF.
    Seckinger P; Dayer JM
    Immunol Ser; 1992; 56():217-36. PubMed ID: 1312873
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential responses of fibroblasts from wild-type and TNF-R55-deficient mice to mouse and human TNF-alpha activation.
    Mackay F; Rothe J; Bluethmann H; Loetscher H; Lesslauer W
    J Immunol; 1994 Dec; 153(11):5274-84. PubMed ID: 7525730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of TNF in lymphocyte-mediated cytotoxicity.
    Smyth MJ; Johnstone RW
    Microsc Res Tech; 2000 Aug; 50(3):196-208. PubMed ID: 10891885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF receptor involvement in TNF-mediated activities against syngeneic malignant and normal mouse thymocytes.
    Fishman M; Larche M
    Cell Immunol; 1993 Dec; 152(2):510-21. PubMed ID: 8258153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor: a plurifunctional mediator of acute inflammation.
    Warren JS; Ward PA; Johnson KJ
    Mod Pathol; 1988 May; 1(3):242-7. PubMed ID: 2853361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid rafts uncouple surface expression of transmembrane TNF-alpha from its cytotoxicity associated with ICAM-1 clustering in Raji cells.
    Zhang S; Liu T; Liang H; Zhang H; Yan D; Wang N; Jiang X; Feng W; Wang J; Li P; Li Z
    Mol Immunol; 2009 Apr; 46(7):1551-60. PubMed ID: 19203796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphotoxin and tumor necrosis factor: qualitative and quantitative differences in their receptors and signal transduction in various cell types.
    Aggarwal BB
    Prog Clin Biol Res; 1990; 349():375-84. PubMed ID: 2169060
    [No Abstract]   [Full Text] [Related]  

  • 13. Triggering of antitumor activity through melanoma-specific transduction of a constitutively active tumor necrosis factor (TNF) R1 chimeric receptor in the absence of TNF-alpha.
    Bazzoni F; Regalia E
    Cancer Res; 2001 Feb; 61(3):1050-7. PubMed ID: 11221832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumor necrosis factor receptor and human neutrophil function. Deactivation and cross-deactivation of tumor necrosis factor-induced neutrophil responses by receptor down-regulation.
    Schleiffenbaum B; Fehr J
    J Clin Invest; 1990 Jul; 86(1):184-95. PubMed ID: 2164042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of receptor-mediated uptake and processing of interferon-alpha 2a and tumor necrosis factor-alpha by human tumor cells.
    Dunne SL; Bajzer Z; Vuk-Pavlović S
    Growth Factors; 1990; 2(2-3):167-77. PubMed ID: 2160259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression.
    Wu S; Boyer CM; Whitaker RS; Berchuck A; Wiener JR; Weinberg JB; Bast RC
    Cancer Res; 1993 Apr; 53(8):1939-44. PubMed ID: 8385577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and cytokine dependent monocyte-mediated leukemic cell death: modulation by interferon-gamma and tumor necrosis factor-alpha.
    van de Loosdrecht AA; Beelen RH; Ossenkoppele GJ; Broekhoven MG; Langenhuijsen MM
    Exp Hematol; 1993 Mar; 21(3):461-8. PubMed ID: 8440344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of type I and type II tumor necrosis factor (TNF) receptors in the ability of TNF-alpha to transduce a proliferative signal in the human megakaryoblastic leukemic cell line Mo7e.
    Liu RY; Fan C; Mitchell S; Chen Q; Wu J; Zuckerman KS
    Cancer Res; 1998 May; 58(10):2217-23. PubMed ID: 9605769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down regulation of the receptors for tumor necrosis factor by interleukin 1 and 4 beta-phorbol-12-myristate-13-acetate.
    Holtmann H; Wallach D
    J Immunol; 1987 Aug; 139(4):1161-7. PubMed ID: 3038998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TNF receptor in TNF-mediated cytotoxicity.
    Kull FC
    Nat Immun Cell Growth Regul; 1988; 7(5-6):254-65. PubMed ID: 2851740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.